qPCR 장비 시장 규모, 점유율, 동향 분석 보고서 : 장비별, 유형별, 지역별, 부문별 예측(2026-2033년)

qPCR Instruments Market Summary

The global qPCR instruments market size was estimated at USD 1.19 billion in 2025 and is expected to reach USD 2.02 billion by 2033, growing at a CAGR of 7.0% from 2026 to 2033. The rising adoption of molecular diagnostics for infectious disease detection, increasing demand for rapid and high sensitivity testing in clinical and research settings, and the expanding use of qPCR in oncology, genetic testing, and precision medicine are identified as the major growth drivers for this market.

The growth has also been supported by advancements in automated and high throughput qPCR platforms, increased public and private funding for life sciences research, and the continued integration of qPCR technologies into public health surveillance and epidemic preparedness programs worldwide.

The rising prevalence of respiratory viruses such as SARS-CoV-2, influenza, and RSV has kept molecular diagnostics central to healthcare infrastructure planning. For instance, in February 2025, Thermo Fisher Scientific announced U.S. FDA approval for Applied Biosystems TaqPath Flu A, Flu B, COVID-19, RSV Select Panel. This PCR-based multiplex test ensures reliable detection and differentiation of these prevalent viruses. It identifies co-infections, underlining the ongoing importance of qPCR-based assays for monitoring seasonal outbreaks. These products increase the utilization of qPCR platforms in clinical labs. They allow a single instrument to run multiple clinically relevant assays. The result is higher throughput and more efficient use of qPCR instruments across diagnostic workflows. These further drive instrument demand in markets focused on public health and clinical readiness.

The demand for qPCR equipment and consumables was heightened during the SARS-CoV-2 pandemic. The spike in incidence of COVID-19 added significantly to the number of preventive screenings. This was attributed to the fact that the number of COVID-19 patients cannot be ascertained without proper screening, owing to the large number of asymptomatic cases.

Launch of new products is further expected to change certain market dynamics, as it can increase the threat of internal substitution. Furthermore, increasing preference of consumers towards updated and advanced products is creating a demand for technologically advanced products, such as the Mic qPCR system with Bluetooth connectivity and multiple devices that can be connected to the computer simultaneously to run multiple sample sets.

qPCR is extensively used for gene expression analysis, SNP genotyping, copy number variation studies, and validation of next-generation sequencing (NGS) data in genomics research. The growing emphasis on precision medicine and functional genomics has increased the need for accurate nucleic acid quantification, reinforcing qPCR's role as a standard laboratory tool. This trend is reflected in ongoing product innovation by major industry players. For instance, in July 2025, Bio-Rad Laboratories expanded its PCR technology portfolio with the launch of advanced Droplet Digital PCR platforms, strengthening its molecular analysis offerings for genomics and oncology research. While digital PCR complements qPCR, such developments underscore the broader expansion of molecular quantification technologies driven by genomics research growth.

Prevalence of chronic diseases, infectious diseases, and genetic disorders such as Alzheimer's, Turner syndrome, & Parkinson's, has increased rapidly, which is expected to fuel the market. According to CDC, chronic diseases such as cancer, diabetes, kidney diseases, and respiratory diseases including asthma, are accountable for 7 in 10 deaths in the U.S. each year. Faster detection of diseases with PCR can allow for timely & appropriate treatment.

Increasing adoption of qPCR technologies is expected to propel this market. Adoption of qPCR techniques is increasing, owing to their accuracy, automation, precise results, real-time quantification, and sensitivity. qPCR offers a wide range of input nucleic acids, making it an effective and useful technology in research applications.

Government initiatives and public-private partnerships are accelerating the adoption of molecular diagnostics in emerging economies. Investments in national reference laboratories, public health programs, and pandemic preparedness have expanded PCR-based testing beyond urban centers. International funding agencies and global health organizations are supporting the deployment of molecular diagnostic platforms. For instance, in May 2025, Siemens Healthineers invested USD 150 million in the U.S., expanding manufacturing, supply depots, and a 60,000 sq. ft. Experience Center, creating jobs and enhancing healthcare innovation nationwide. These investments further drive qPCR instrument penetration in resource-limited settings.

Global qPCR Instruments Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global qPCR instruments market report based on instruments, type, and region:

• Instruments Outlook (Revenue, USD Million, 2021 - 2033)
• 7500
• QuantStudio
• StepOne/StepOne Plus
• LightCycler
• Cobas 4800/5800/6800/8800
• GeneXpert
• Rotor-Gene Q
• BioFire FilmArray Systems
• BMS Mic System
• Cobas Z480
• CFX
• Others
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Standalone qPCR Instruments
• Integrated/Automated Molecular Systems
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Regional scope
  • 1.1.2 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis (Model 1)
    • 1.6.1.1 Approach 1: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Instruments Test Type Snapshot
• 2.3 Competitive Landscape Snapshot

Chapter 3 qPCR Instruments Market Variables, Trends & Scope

• 3.1 qPCR Instruments Market Lineage Outlook
  • 3.1.1 Parent market outlook
  • 3.1.2 Related/Ancillary Market Outlook
• 3.2 Regulatory and Reimbursement Framework
• 3.3 Market Dynamics
  • 3.3.1 Market driver analysis
    • 3.3.1.1 Rising Demand for Molecular Diagnostics
    • 3.3.1.2 Growth in Genomics, Proteomics, and Life Science Research
    • 3.3.1.3 Technological advancements and product Innovation
  • 3.3.2 Market restraint analysis
    • 3.3.2.1 High Instrument and Maintenance Costs
    • 3.3.2.2 Availability of Alternative and Advanced Technologies
  • 3.3.3 Market opportunity analysis
    • 3.3.3.1 Expansion of Molecular Diagnostics in Emerging Markets
    • 3.3.3.2 Growing Adoption of qPCR in Precision Medicine and Oncology
• 3.4 Porter's Five Forces Analysis
• 3.5 qPCR Instruments Market Analysis Tools
• 3.6 PESTEL Analysis

Chapter 4 qPCR Instruments Market: Segment Analysis, by Instruments, 2021 - 2033 (USD Million)

• 4.1 Global qPCR Instrument Market: Instrument Movement Analysis
• 4.2 qPCR Market Estimates & Forecast, by Instruments (USD Million)
• 4.3 7500
  • 4.3.1 7500 Market, 2021 - 2033 (USD Million)
• 4.4 QuantStudio
  • 4.4.1 QuantStudio Market, 2021 - 2033 (USD Million)
• 4.5 StepOne/StepOne Plus
  • 4.5.1 StepOne/StepOne Plus Market, 2021 - 2033 (USD Million)
• 4.6 LightCycler
  • 4.6.1 LightCycler Market, 2021 - 2033 (USD Million)
• 4.7 Cobas 4800/5800/6800/8800
  • 4.7.1 Cobas 4800/5800/6800/8800 Market, 2021 - 2033 (USD Million)
• 4.8 GeneXpert
  • 4.8.1 GeneXpert Market, 2021 - 2033 (USD Million)
• 4.9 Rotor-Gene Q
  • 4.9.1 Rotor-Gene Q Market, 2021 - 2033 (USD Million)
• 4.10 BIOFIRE FILMARRAY SYSTEMS
  • 4.10.1 BIOFIRE FILMARRAY SYSTEMS Market, 2021 - 2033 (USD Million)
• 4.11 Cobas z480
  • 4.11.1 Cobas z480 Market, 2021 - 2033 (USD Million)
• 4.12 CFX
  • 4.12.1 CFX Market, 2021 - 2033 (USD Million)
• 4.13 BMS Mic System
  • 4.13.1 BMS Mic System Market, 2021 - 2033 (USD Million)
• 4.14 Others
  • 4.14.1 Others Market, 2021 - 2033 (USD Million)

Chapter 5 qPCR Instruments Market: Segment Analysis, by Type, 2021 - 2033 (USD Million)

• 5.1 Global qPCR Type Market: Instrument Movement Analysis
• 5.2 qPCR Market Estimates & Forecast, by Instruments (USD Million)
• 5.3 Standalone qPCR Instruments
  • 5.3.1 Standalone qPCR Instruments Market, 2021 - 2033 (USD Million)
• 5.4 Integrated/Automated Molecular Systems
  • 5.5.1 Integrated/Automated Molecular Systems Market, 2021 - 2033 (USD Million)

Chapter 6 qPCR Instruments Market: Regional Market Analysis, 2021 - 2033 (USD Million)

• 6.1 qPCR Instruments Market: Regional Outlook
• 6.2 North America
  • 6.2.1 North America qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.2.2 U.S.
    • 6.2.2.1 Key Country Dynamics
    • 6.2.2.2 U.S. qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.2.3 Competitive/Market Scenario
    • 6.2.2.4 Regulatory Framework
    • 6.2.2.5 Reimbursement Scenario
  • 6.2.3 Canada
    • 6.2.3.1 Key Country Dynamics
    • 6.2.3.2 Canada qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.3.3 Competitive/Market Scenario
    • 6.2.3.4 Regulatory Framework
    • 6.2.3.5 Reimbursement Scenario
  • 6.2.4 Mexico
    • 6.2.4.1 Key Country Dynamics
    • 6.2.4.2 Mexico qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.2.4.3 Competitive/Market Scenario
    • 6.2.4.4 Regulatory Framework
    • 6.2.4.5 Reimbursement Scenario
• 6.3 Europe
  • 6.3.1 Europe qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3.2 UK
    • 6.3.2.1 Key Country Dynamics
    • 6.3.2.2 UK qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2.3 Competitive/Market Scenario
    • 6.3.2.4 Regulatory Framework
    • 6.3.2.5 Reimbursement Scenario
  • 6.3.3 Germany
    • 6.3.3.1 Key Country Dynamics
    • 6.3.3.2 Germany qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3.3 Competitive/Market Scenario
    • 6.3.3.4 Regulatory Framework
    • 6.3.3.5 Reimbursement Scenario
  • 6.3.4 France
    • 6.3.4.1 Key Country Dynamics
    • 6.3.4.2 France qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4.3 Competitive/Market Scenario
    • 6.3.4.4 Regulatory Framework
    • 6.3.4.5 Reimbursement Scenario
  • 6.3.5 Spain
    • 6.3.6.1 Key Country Dynamics
    • 6.3.6.2 Spain qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6.3 Competitive/Market Scenario
    • 6.3.6.4 Regulatory Framework
    • 6.3.6.5 Reimbursement Scenario
  • 6.3.6 Italy
    • 6.3.6.1 Key Country Dynamics
    • 6.3.6.2 Italy qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6.3 Competitive/Market Scenario
    • 6.3.6.4 Regulatory Framework
    • 6.3.6.5 Reimbursement Scenario
  • 6.3.7 Denmark
    • 6.3.7.1 Key Country Dynamics
    • 6.3.7.2 Denmark qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7.3 Competitive/Market Scenario
    • 6.3.7.4 Regulatory Framework
    • 6.3.7.5 Reimbursement Scenario
  • 6.3.8 Sweden
    • 6.3.8.1 Key Country Dynamics
    • 6.3.8.2 Sweden qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.8.3 Competitive/Market Scenario
    • 6.3.8.4 Regulatory Framework
    • 6.3.8.5 Reimbursement Scenario
  • 6.3.9 Norway
    • 6.3.9.1 Key Country Dynamics
    • 6.3.9.2 Norway qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.9.3 Competitive/Market Scenario
    • 6.3.9.4 Regulatory Framework
    • 6.3.9.5 Reimbursement Scenario
• 6.4 Asia Pacific
  • 6.4.1 Asia Pacific qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4.2 Japan
    • 6.4.2.1 Key Country Dynamics
    • 6.4.2.2 Japan qPCR Instruments Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2.3 Competitive/Market Scenario
    • 6.4.2.4 Regulatory Framework
    • 6.4.2.5 Reimbursement Scenario
  • 6.4.3 China
    • 6.4.3.1 Key Country Dynamics
    • 6.4.3.2 China qPCR Instruments Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3.3 Competitive/Market Scenario
    • 6.4.3.4 Regulatory Framework
    • 6.4.3.5 Reimbursement Scenario
  • 6.4.4 India
    • 6.4.4.1 Key Country Dynamics
    • 6.4.4.2 India qPCR Instruments Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4.3 Competitive/Market Scenario
    • 6.4.4.4 Regulatory Framework
    • 6.4.4.5 Reimbursement Scenario
  • 6.4.5 Australia
    • 6.4.6.1 Key Country Dynamics
    • 6.4.6.2 Australia qPCR Instruments Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6.3 Competitive/Market Scenario
    • 6.4.6.4 Regulatory Framework
    • 6.4.6.5 Reimbursement Scenario
  • 6.4.6 South Korea
    • 6.4.6.1 Key Country Dynamics
    • 6.4.6.2 South Korea qPCR Instruments Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6.3 Competitive/Market Scenario
    • 6.4.6.4 Regulatory Framework
    • 6.4.6.5 Reimbursement Scenario
• 6.5 Latin America
  • 6.6.1 Latin America qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2 Brazil
    • 6.6.2.1 Key Country Dynamics
    • 6.6.2.2 Brazil qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2.3 Competitive/Market Scenario
    • 6.6.2.4 Regulatory Framework
    • 6.6.2.5 Reimbursement Scenario
  • 6.6.3 Argentina
    • 6.6.3.1 Key Country Dynamics
    • 6.6.3.2 Argentina qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3.3 Competitive/Market Scenario
    • 6.6.3.4 Regulatory Framework
    • 6.6.3.5 Reimbursement Scenario
• 6.6 MEA (Middle East & Africa)
  • 6.6.1 MEA qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6.2 South Africa
    • 6.6.2.1 Key Country Dynamics
    • 6.6.2.2 South Africa qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2.3 Competitive/Market Scenario
    • 6.6.2.4 Regulatory Framework
    • 6.6.2.5 Reimbursement Scenario
  • 6.6.3 Saudi Arabia
    • 6.6.3.1 Key Country Dynamics
    • 6.6.3.2 Saudi Arabia qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3.3 Competitive/Market Scenario
    • 6.6.3.4 Regulatory Framework
    • 6.6.3.5 Reimbursement Scenario
  • 6.6.4 UAE
    • 6.6.4.1 Key Country Dynamics
    • 6.6.4.2 UAE qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4.3 Competitive/Market Scenario
    • 6.6.4.4 Regulatory Framework
    • 6.6.4.5 Reimbursement Scenario
  • 6.6.5 Kuwait
    • 6.6.6.1 Key Country Dynamics
    • 6.6.6.2 Kuwait qPCR Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6.3 Competitive/Market Scenario
    • 6.6.6.4 Regulatory Framework
    • 6.6.6.5 Reimbursement Scenario

Chapter 7 COMPETITIVE LANDSCAPE

• 7.1 Company Categorization
• 7.2 Participants' Overview
• 7.3 Financial Performance
• 7.4 Product Benchmarking
• 7.5 Strategy Mapping
  • 7.5.1 Mergers & Acquisitions
  • 7.5.2 Partnerships and Collaborations
  • 7.5.3 New Product Launch
• 7.6 Company Profiles
  • 7.6.1 Thermo Fisher Scientific, inc.
    • 7.6.1.1 Company Overview
    • 7.6.1.2 Financial Performance
    • 7.6.1.3 Product Benchmarking
    • 7.6.1.4 Strategic Initiatives
  • 7.6.2 F. Hoffmann-La Roche Ltd.
    • 7.6.2.1 Company Overview
    • 7.6.2.2 Financial Performance
    • 7.6.2.3 Product Benchmarking
    • 7.6.2.4 Strategic Initiatives
  • 7.6.3 Bio-Rad Laboratories, Inc.
    • 7.6.3.1 Company Overview
    • 7.6.3.2 Financial Performance
    • 7.6.3.3 Product Benchmarking
    • 7.6.3.4 Strategic Initiatives
  • 7.6.4 Danaher Corporation
    • 7.6.4.1 Company Overview
    • 7.6.4.2 Financial Performance
    • 7.6.4.3 Product Benchmarking
    • 7.6.4.4 Strategic Initiatives
  • 7.6.5 Qiagen
    • 7.6.5.1 Company Overview
    • 7.6.5.2 Financial Performance
    • 7.6.5.3 Product Benchmarking
    • 7.6.5.4 Strategic Initiatives
  • 7.6.6 Agilent Technologies, Inc.
    • 7.6.6.1 Company Overview
    • 7.6.6.2 Financial Performance
    • 7.6.6.3 Product Benchmarking
    • 7.6.6.4 Strategic Initiatives
  • 7.6.7 Abbott
    • 7.6.7.1 Company Overview
    • 7.6.7.2 Alere, Inc.
    • 7.6.7.3 Financial Performance
    • 7.6.7.4 Product Benchmarking
    • 7.6.7.5 Strategic Initiatives
  • 7.6.8 bioMerieux SA
    • 7.6.8.1 Company Overview
    • 7.6.8.2 Financial Performance
    • 7.6.8.3 Product Benchmarking
    • 7.6.8.4 Strategic Initiatives
  • 7.6.9 Quantabio
    • 7.6.9.1 Company Overview
    • 7.6.9.2 Product Benchmarking
    • 7.6.9.3 Strategic Initiatives
  • 7.6.10 Azure Biosystems, Inc.
    • 7.6.10.1 Company Overview
    • 7.6.10.2 Product Benchmarking
    • 7.6.10.3 Strategic Initiatives
  • 7.6.11 Bio Molecular Systems
    • 7.6.11.1 Company Overview
    • 7.6.11.2 Product Benchmarking
    • 7.6.11.3 Strategic Initiatives